Ulove Protein: Targeting Popular USP Targets for Scientific Breakthroughs

In the realm of deubiquitinating enzymes (DUBs), the USP family undeniably takes center stage. With 56 members identified in humans, the USP family exhibits immense potential across oncology, immunomodulation, and beyond. Ulove Protein offers a comprehensive suite of USP proteins to empower your research endeavors!

USP7: A "Key Player" in Cancer Therapy

USP7 is overexpressed in multiple cancers, including chronic lymphocytic leukemia, prostate cancer, and glioma. By regulating the p53-MDM2 signaling axis, it influences cell cycle progression and apoptosis, fueling tumor development. Additionally, USP7 modulates critical proteins like PTEN and FOXO4, promoting cancer onset and metastasis. Ulove Protein provides high-purity, high-activity USP7 to facilitate in-depth studies of its oncogenic mechanisms.

Figure 1. Activity Assay of Ulove USP7 Protein

USP1: A "Master Regulator" of DNA Damage Repair

USP1 plays a pivotal role in DNA damage response and repair. By deubiquitinating PCNA in the translesion synthesis (TLS) pathway, it maintains genomic stability. Dysregulation of USP1 is also linked to tumorigenesis and chemoresistance. Ulove Protein's USP1 supports exploration of its therapeutic potential in cancer.

Figure 2. Activity Assay of Ulove USP1 Protein

USP30: A "New Hope" for Liver Cancer Treatment

Research shows that USP30 is highly expressed in hepatocellular carcinoma (HCC) tissues and cells, promoting proliferation, invasion, and migration. This makes USP30 a promising target for HCC diagnosis and treatment. Ulove Protein offers premium USP30 to advance your HCC research.

Figure 3. Activity Assay of Ulove USP30 Protein

USP11: A "Hidden Driver" of Hepatocellular Carcinoma

In HCC, USP11 upregulation correlates with tumor aggressiveness and poor prognosis. It drives HCC progression by promoting epithelial-mesenchymal transition (EMT) and metastasis. Rigorous validation ensures Ulove Protein's USP11 is a robust tool for HCC studies.

USP14: A "Multifaceted Regulator" in Oncology

Aberrantly overexpressed in various malignancies, USP14 modulates targets such as the androgen receptor and cell cycle proteins, impacting tumor cell proliferation, apoptosis, and drug resistance. Its inhibitors have demonstrated potent antitumor effects. Ulove Protein's USP14 aids in developing novel USP14-targeted therapies.

Committed to delivering superior USP protein products, Ulove Protein is your partner in scientific discovery. Choose Ulove Protein for a comprehensive USP portfolio—smooth your research journey!

Technical Articles